A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595

Clinical trial NCT02134834 · COMPLETED

Trial details

NCT number: NCT02134834
Sponsor: Meiji Seika Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bacterial Infections

Start date: 2014-05-01
Primary completion: 2014-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.